2014
DOI: 10.4103/1687-9090.143259
|View full text |Cite
|
Sign up to set email alerts
|

Ascorbic acid versus magnesium for the prevention of atrial fibrillation after coronary artery bypass grafting surgery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
18
0
1

Year Published

2016
2016
2020
2020

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 9 publications
(19 citation statements)
references
References 0 publications
0
18
0
1
Order By: Relevance
“…Finally, we perused the reference lists of the selected trials and relevant reviews, from which we discovered two more trials. We identified nine trials satisfying our selection criteria [11][12][13][14][15][16][17][18][19]. We did not include two further trials that reported "ventilator-free days" since we were unable to convert this to our outcome of interest, "duration of mechanical ventilation" [20,21].…”
Section: Methodsmentioning
confidence: 99%
See 4 more Smart Citations
“…Finally, we perused the reference lists of the selected trials and relevant reviews, from which we discovered two more trials. We identified nine trials satisfying our selection criteria [11][12][13][14][15][16][17][18][19]. We did not include two further trials that reported "ventilator-free days" since we were unable to convert this to our outcome of interest, "duration of mechanical ventilation" [20,21].…”
Section: Methodsmentioning
confidence: 99%
“…Thus, we The searches were carried out on 13 Nov 2019. The searches identified nine trials that we included in our systematic review analysis [11][12][13][14][15][16][17][18][19] and eight of them were included in our meta-analysis [11][12][13][14][15][16][17][18] calculated that the average dose was 90 g/day in the Tanaka trial. Zabet et al administered 25 mg/kg every 6 h, but the mean weight was not reported [18].…”
Section: Methodsmentioning
confidence: 99%
See 3 more Smart Citations